Table 2 (abstract P499). Comparison of actual and perceived APs prescribed doses when treating critical care delirium
From: 38th International Symposium on Intensive Care and Emergency Medicine
AP | Starting dose mg (a) Median IQ | Maximum daily dose mg/day (b) Median IQ | Audit vs. Survey comparison P value |
|---|---|---|---|
Oral quetiapine-survey (63.8%) | 25 (12.5-25) | 200 (100-300) | (a) 0.205 |
Oral-quetiapine audit (42.6%) | 25 (13-31) | 100 (50-200) | (b) 0.014* |
IV haloperidol-survey (26%) | 1 (1-2.5) | 2.5 (1.2-17) | (a) 0.33 |
IV haloperidol audit (22%) | 1 (0.6-1) | 16 (10-20) | (b) 0.003* |
Oral-olanzapine-survey (11%) | 2.5 (2.5-5) | 5 (2.5-5) | (a) 0.6 |
Oral-olanzapine audit (22%) | 20 (10-20) | 1- (5-19) | (b) 0.2 |